NextEra Energy CEO says natural gas can meet only small part of surging U.S. power demandMarch 11, 2025
Market Trends Beam drops 9% on phase 1/2 data for genetic lung disease candidateBy admin8996erT0allMarch 10, 2025 Hiroshi Watanabe Beam Therapeutics (NASDAQ:BEAM) is down ~9% in Monday afternoon trading after reporting initial phase 1/2 data on BEAM-302…
Market Trends Beam upgraded by Bernstein ahead of AATD data (BEAM:NASDAQ)By admin8996erT0allJanuary 7, 2025 sutthirat sutthisumdangBernstein has upgraded Beam Therapeutics (NASDAQ:BEAM) to outperform from market perform, citing upcoming data on the company’s drug candidate…
